Alexey Aronov’s area of focus is customs law and he deals with a wide range of customs issues including valuations, disputes, classifications, tariffs, IP protection and exemptions, including issues which arise when structuring a transaction.
He regularly acts for clients before customs authorities in relation to proving initially declared customs values which have been rejected by the customs authorities. He has advised a number of manufacturers on the import of production equipment, obtaining customs classification under a single tariff code, achieving zero customs duty and VAT relief.
Alexey also advises clients on the development of supply chains, including spare parts delivery related to production equipment.
He has also successfully represented numerous clients in administrative disputes and appeals to customs authorities in relation to a wide range of customs matters.
Life Scienes Practice:
As the legal matters confronting our life science clients are varied, so are the skill sets we employ. DLA Piper’s life sciences team comprises lawyers with legal, scientific and medical knowledge who understand the complexity of the business and regulatory environments in which our clients operate.
The challenges facing today’s biotechnology and medical device companies are greater than ever. For companies to take promising therapies from the laboratory to the market, they must protect those therapies from IP, regulatory and reputational risks. Furthermore, the last few years have seen increasing pressure from many sides: demand for greater shareholder return, loss of key revenue streams due to patent expiration or generic challenges, fierce competition in key therapeutic areas, pricing pressures from health care payors, increased government regulation beyond core safety issues, rising costs of R&D, challenges in maximizing return in emerging markets and aggressive government enforcement action.
Our life sciences sector team is one of the largest and most active of any law firm. Operating as one team across more than 30 jurisdictions, we combine subject matter experience with considerable knowledge of the sector, including the scientific, medical, regulatory, commercial and enforcement environments facing our biopharmaceutical, medical device, research and diagnostics clients.